Long-term results of Nivolumab + Cabozantinib in RCC

Published Date: 08 Mar 2023

The combination of first-line nivolumab and cabozantinib continues to outperform sunitinib in the treatment of patients with advanced renal cell carcinoma (RCC).

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

2.

Year in Review: Non-Small Cell Lung Cancer

3.

FDA Approves Hemophilia B Second Gene Therapy.

4.

Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.

5.

Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot